ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0

CUSIP: 464337AG9

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Debt / NOTE 2.750%10/0
Market price (% of par)
373.67%
Total 13F principal
$55,605,000
Principal change
+$1,634,000
Total reported market value
$207,636,000
Number of holders
7
Value change
+$6,109,614
Number of buys
3
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 464337AG9?
CUSIP 464337AG9 identifies 464337AG9 - ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0 as of Q4 2015

As of 31 Dec 2015, ISIS PHARMACEUTICALS INC DEL - NOTE 2.750%10/0 was held by 7 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $55,605,000 in principal (par value) of the bond. The largest 7 bondholders included WOLVERINE ASSET MANAGEMENT LLC, WHITEBOX ADVISORS LLC, FMR LLC, Nantahala Capital Management, LLC, EQUITEC SPECIALISTS, LLC, WELLS FARGO & COMPANY/MN, and BANK OF AMERICA CORP /DE/. This page lists 7 institutional bondholders reporting positions for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.